1,801 reports of this reaction
2.5% of all HUMAN IMMUNOGLOBULIN G reports
#6 most reported adverse reaction
SINUSITIS is the #6 most commonly reported adverse reaction for HUMAN IMMUNOGLOBULIN G, manufactured by ADMA Biologics, Inc.. There are 1,801 FDA adverse event reports linking HUMAN IMMUNOGLOBULIN G to SINUSITIS. This represents approximately 2.5% of all 73,013 adverse event reports for this drug.
Patients taking HUMAN IMMUNOGLOBULIN G who experience sinusitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SINUSITIS is a less commonly reported adverse event for HUMAN IMMUNOGLOBULIN G, but still significant enough to appear in the safety profile.
In addition to sinusitis, the following adverse reactions have been reported for HUMAN IMMUNOGLOBULIN G:
The following drugs have also been linked to sinusitis in FDA adverse event reports:
SINUSITIS has been reported as an adverse event in 1,801 FDA reports for HUMAN IMMUNOGLOBULIN G. This does not prove causation, but indicates an association observed in post-market surveillance data.
SINUSITIS accounts for approximately 2.5% of all adverse event reports for HUMAN IMMUNOGLOBULIN G, making it a notable side effect.
If you experience sinusitis while taking HUMAN IMMUNOGLOBULIN G, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.